In this episode, MM+M Pharma Editor Lecia Bushak sits down with Noom’s CEO Geoff Cook and Chief Medical Officer Dr. Jeffrey Egler to discuss the launch of their new Microdose GLP-1 program, designed to help people lose weight with smaller doses of the popular obesity drugs. They delve into the benefits of “micro-dosing” GLP-1s and the behavioral health components of Noom’s model that aims to support long-term weight loss. Egler and Cook break down the challenges of drug pricing and accessibility, as well as the future of the obesity market.
Check us out at: mmm-online.com
Follow us:
YouTube: @MMM-online
TikTok: @MMMnews
Instagram: @MMMnewsonline
Twitter/X: @MMMnews
LinkedIn: MM+M
To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.
Music: “Deep Reflection” by DP and Triple Scoop Music.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
